The Yuzu Story

Advancing Pain Relief Through Medical Cannabis Research

Seven years ago, a group of physicians and scientists came together with a shared vision: to explore the therapeutic potential of cannabinoids with a strong emphasis on evidence-informed wellness.

In June 2018, our team shared preliminary research at the American Society of Clinical Oncology. The study observed a reduction in opioid use among patients managing chronic pain with a combination of THC and CBD. These findings were featured on several media outlets and published in peer-reviewed journals.¹

However, as the broader cannabis market shifted toward recreational use, we chose to exit the THC space to stay aligned with our medical and wellness-focused mission. Today, we’re fully dedicated to CBD—a path we believe better serves both human and animal wellness.

We clearly understand the potential of cannabinoids to affect overall wellness and think the CBD arena is more in line with our goals as a company: impacting both human and animal wellness.

WHY CHOOSE OUR YUZU?

a PHYSCIAN-FOUNDED COMPANY

As a physician-founded company, we place high value on transparency, integrity, and scientific rigor. While there is a growing body of anecdotal evidence suggesting that cannabinoids may offer wellness support—particularly for joint health, stress, and inflammation-related concerns—robust clinical data is still emerging. At YUZU CBDplus, we advocate for continued research and remain committed to sharing reputable sources, including references from PubMed®, to help customers make informed decisions. Our formulas include ingredients such as glucosamine, chondroitin, MSM, and yuzu citrus—known for its antioxidant and anti-inflammatory properties—carefully selected to complement our broad-spectrum CBD.

HIGH-QUALITY CBD, ENHANCED FOR WELLNESS

We offer broad-spectrum CBD products including salves, lotions, tinctures, suppositories, and edibles. Each formulation is the result of two years of development with experienced chemists and world-renowned chef Jean-Marie Auboine. Our goal is to create products that are not only effective but enjoyable to use—delivering quality without compromise.

American Society of Clinical Oncology

In 2018, members of our founding team presented observational data at the American Society of Clinical Oncology exploring the potential of a THC/CBD combination in reducing opioid use among patients with chronic pain. The presentation received attention from medical professionals and was later covered by media and scientific publications.¹

While our company now focuses exclusively on CBD products, we continue to support research and responsible education around cannabinoid science.

PHYSICIANS. SCIENTISTS. ARTISTRY.

Behind our products is a team with over 175 years of combined medical experience across fields such as oncology, gynecology, pulmonology, and more. Our founders have contributed to over 175 scientific publications, been involved in more than 500 clinical trials, and received numerous professional recognitions.

Alongside our clinical expertise, we’ve partnered with skilled chemists and award-winning chef Jean-Marie Auboine to blend scientific precision with artisanal quality.

TRUSTED FORMULATIONS. VERIFIED PURITY.

Every batch of YUZU CBDplus is third-party tested to ensure quality, purity, and potency. Lab results are available for every product so you can trust what’s in the bottle—clean, consistent, and safe CBD.

LAB REPORTS